Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s interface/version indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software/UI revision rather than any substantive update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:41.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:50.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision v3.5.0 was added to the history and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:24:31.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update only changes version labels in the history section and does not modify study data or page content.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:49.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an old government-funding/operating-status notice was deleted.
    Difference
    0.6%
    Check dated 2026-02-11T14:29:31.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the revision history now shows v3.4.1 replacing v3.4.0. These updates are informational and do not affect study details, results, or user interactions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T10:42:58.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.